HPV Vaccines + Screenings May Reduce Cervical Lesions


Sex Education for the Real World…


HPV Vaccines + Screenings May Reduce Cervical Lesions

Posted June 18, 2015 by Kimani in Sex Health
HPV Vaccines

New breakthroughs in HPV Vaccines studies are very encouraging in the sex health world. Not only do we need to build awareness on STDs and the dangers they can lead to, but we need to study these diseases to watch how they evolve and progress. Hopefully these advances can help control and ultimately eradicate the disease overall…

A new analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening.

More than half of high-grade cervical lesions, which are abnormal tissue changes that can lead to cancer, are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

A team led by Susan Hariri, PhD, of the US Centers for Disease Control and Prevention, found that in the first few years after HPV vaccination was introduced in the United States (2008-2012), there were large and uniform declines in high-grade cervical lesions in young women across the country who were aged 18 to 20 years, and to a lesser extent, in women aged 21 to 24 years.

Dr. Hariri noted that high-grade cervical lesions are asymptomatic and can only be detected through routine cervical cancer screening. Because screening recommendations were changing during the time period of this study, the investigators also looked at trends in cervical cancer screening utilization. “In particular, screening is no longer recommended in women before age 21 years, and we found substantial declines in screening in 18 to 20 year olds that were consistent with the new recommendations,” said Dr. Hariri. While screening also declined in 21 to 24 year old women, the decreases in screening were much smaller. “We think that the decreases in high-grade lesions in this group reflect changes in screening but also may be partially due to HPV vaccination.” Dr. Hariri added that the greatest benefit of HPV vaccination—reducing the burden of cervical cancer and other HPV-associated cancers—will take many years to evaluate because of the long lag time between infection with HPV and the development of cancer.

In an accompanying editorial, Harinder Brar, MD and Allan Covens, MD, of the University of Toronto, stated that the study is significant because it is the first to look at the incidence trends of high-grade cervical lesions in the post-vaccination era. “The study highlights that while preliminary data demonstrates a drop in… incidence rates, the results may be confounded by the changes in cervical screening guidelines.”


Source: Wiley Science Newsroom

About the Author


A NY transplant in Florida, Kimani has taken on the task of educating the world on sexual health and education. The Mount Vernon native has seen AIDS and HIV spread through her community like wildfire, and hopes to cease the transmission of these and other diseases one person at a time. If you know better, you're inclined to do better.

LIKING us on Facebook helps our Vadge GROW!
Click like on Facebook to get VforVadge news straight to your timeline!
%d bloggers like this: